T Scientific Co.,Ltd. (KOSDAQ:057680)
South Korea · Delayed Price · Currency is KRW 586.00
+9.00 (1.56%)
At close: Apr 8, 2026
T Scientific Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 36,366 | 43,017 | 26,769 | 8,694 | 10,084 |
| 36,366 | 43,017 | 26,769 | 8,694 | 10,084 | |
Revenue Growth (YoY) | -15.46% | 60.70% | 207.89% | -13.78% | -66.14% |
Cost of Revenue | 25,366 | 33,116 | 18,685 | 4,510 | 5,833 |
Gross Profit | 11,000 | 9,901 | 8,084 | 4,184 | 4,250 |
Selling, General & Admin | 7,534 | 8,361 | 11,235 | 5,517 | 2,538 |
Research & Development | 2,050 | 1,265 | 902.9 | 273.43 | 296.59 |
Amortization of Goodwill & Intangibles | 64.27 | 150.66 | 170 | 124.78 | 92.93 |
Other Operating Expenses | 184.19 | 406.9 | 438.4 | 360.24 | 135.47 |
Operating Expenses | 10,736 | 20,533 | 13,700 | 6,676 | 3,247 |
Operating Income | 264.33 | -10,632 | -5,616 | -2,492 | 1,004 |
Interest Expense | -786.3 | -866.07 | -2,711 | -2,938 | -1,285 |
Interest & Investment Income | 184.27 | 342.04 | 488.13 | 555.77 | 136.53 |
Currency Exchange Gain (Loss) | 2.55 | -5.02 | -0 | 0.04 | - |
Other Non Operating Income (Expenses) | -1,029 | 8,371 | -5,678 | -2,380 | -1,405 |
EBT Excluding Unusual Items | -1,365 | -2,790 | -13,516 | -7,254 | -1,550 |
Gain (Loss) on Sale of Investments | -812.86 | 3,466 | -14,018 | -8,590 | -1,417 |
Gain (Loss) on Sale of Assets | -1,414 | -203.75 | 16.6 | -46.48 | 7.95 |
Asset Writedown | -1,257 | -115.73 | -26,707 | - | - |
Other Unusual Items | - | 951.9 | -37.64 | - | - |
Pretax Income | -4,849 | 1,308 | -54,262 | -15,890 | -2,959 |
Income Tax Expense | -3,250 | -981.28 | -5,525 | -4,082 | 202.86 |
Earnings From Continuing Operations | -1,599 | 2,289 | -48,737 | -11,808 | -3,162 |
Minority Interest in Earnings | 318.58 | -65.9 | 3,323 | 698 | - |
Net Income | -1,281 | 2,223 | -45,414 | -11,110 | -3,162 |
Net Income to Common | -1,281 | 2,223 | -45,414 | -11,110 | -3,162 |
Shares Outstanding (Basic) | 71 | 69 | 62 | 53 | 47 |
Shares Outstanding (Diluted) | 71 | 69 | 62 | 53 | 47 |
Shares Change (YoY) | 2.39% | 12.72% | 16.46% | 12.96% | 183.72% |
EPS (Basic) | -18.00 | 32.00 | -736.71 | -209.91 | -67.48 |
EPS (Diluted) | -18.00 | 32.00 | -737.00 | -210.00 | -67.48 |
Free Cash Flow | 638.15 | -13,259 | -11,388 | -2,667 | -123.56 |
Free Cash Flow Per Share | 8.97 | -190.82 | -184.74 | -50.39 | -2.64 |
Gross Margin | 30.25% | 23.02% | 30.20% | 48.13% | 42.15% |
Operating Margin | 0.73% | -24.71% | -20.98% | -28.66% | 9.96% |
Profit Margin | -3.52% | 5.17% | -169.65% | -127.79% | -31.36% |
Free Cash Flow Margin | 1.75% | -30.82% | -42.54% | -30.68% | -1.23% |
EBITDA | 1,275 | -9,282 | -4,279 | -2,067 | 1,269 |
EBITDA Margin | 3.51% | -21.58% | -15.99% | -23.77% | 12.59% |
D&A For EBITDA | 1,011 | 1,349 | 1,337 | 425.18 | 265.68 |
EBIT | 264.33 | -10,632 | -5,616 | -2,492 | 1,004 |
EBIT Margin | 0.73% | -24.71% | -20.98% | -28.66% | 9.96% |
Advertising Expenses | 79.83 | 64.18 | 25.32 | 35.82 | 25.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.